Congenital cytomegalovirus (CMV) infections are a leading cause of sensorineural hearing loss (SNHL) and neurological impairment. Congenital transmission of CMV can occur with maternal primary infection, reactivation, or reinfection during pregnancy. We reviewed studies of CMV shedding in bodily fluids (defined as CMV detected by culture or CMV DNA detected by polymerase chain reaction). Following diagnosis at birth, children with congenital CMV infection exhibited the highest prevalences of CMV shedding (median = 80%, number of sample population prevalences [N] = 6) and duration of shedding, with a steep decline by age five. Healthy children attending day care shed more frequently (median = 23%, N = 24) than healthy children not attending day care (median = 12%, N = 11). Peak shedding prevalences in children occurred at 1-2 years of age, confirming that young children are the key transmission risk for pregnant women. CMV shedding among children was more prevalent in urine specimens than in oral secretions (median prevalence difference = 11.5%, N = 12). Adults with risk factors such as STD clinic attendance had higher shedding prevalences (median = 22%, N = 20) than adults without risk factors (median = 7%, N = 44). In adults with risk factors, CMV was shed more frequently in urine; in adults without risk factors genital shedding was most common. The prevalence of CMV shedding in nine sample populations of pregnant women increased with advancing gestation. In seven sample populations of children with congenital CMV infection, higher viral load at birth was consistently associated with an elevated risk of SNHL. Higher CMV viral load at birth also consistently correlated with the presence of symptoms of congenital CMV at birth. Published 2011. This article is a US Government work and is in the public domain in the USA.
INTRODUCTION
Adults can become infected with cytomegalovirus (CMV) through a variety of transmission routes, including contact with bodily fluids of children or adults who are shedding the virus, sexual activity, blood transfusion, and organ transplantation [1] . In most cases, CMV infection in immunocompetent adults does not lead to symptomatic disease [1] ; however, active CMV infection during pregnancy can result in transmission to the fetus [2] that can in turn result in permanent damage, including SNHL, intellectual disability and, rarely, death [3, 4] . The risk of permanent damage appears to be highest among children whose mother experienced primary CMV infection during gestation [5, 6] . It has been estimated that more than half a million women of child-bearing age in the United States of America will experience primary CMV infection each year [7] .
As with all human herpesviruses, CMV establishes a life-long latent infection during primary infection, and the virus may reactivate at any time with shedding of infectious CMV in saliva, urine and other bodily secretions [1] . Reinfection with a different CMV strain is also associated with shedding [5] . CMV infection and shedding are generally asymptomatic [8] , so that individuals are unlikely to know that they have been infected or are shedding the virus. Infants and young children often acquire CMV infection through breastfeeding [9, 10] or through contact with other children who are actively shedding virus [11] . Infants and young children may continue shedding virus for a year or more, and probably serve as the leading source for primary infection in women of reproductive age [12] [13] [14] [15] [16] .
In order to better understand exposures that place women at risk for CMV primary infection or reinfection during pregnancy, we reviewed the available literature on the frequency, magnitude, and risk factors for CMV shedding in various populations.
METHODS

Definition of terms
In this review, we define CMV 'shedding' as the presence of CMV detected by culture techniques (e.g. traditional or rapid shell vial) or CMV DNA detected by polymerase chain reaction (PCR; e.g. nested or non-nested) [17] . The testing method is specified in the Tables.
For simplicity and to facilitate comparisons, specimens from the oral cavity, including throat swabs and mouth rinses, were categorized as 'oral secretions'; cervical and vaginal swabs and lavages were categorized as 'genital secretions'; and white blood cells, peripheral blood mononuclear cells, and peripheral mononuclear lymphocytes were categorized as 'blood'.
type (e.g. urine and oral secretions), or more than one time point (e.g. all three pregnancy trimesters). We used the term 'sample population prevalence' to specify each of these shedding prevalences. Thus, some of the figures have more than one data point from a single study. These multiple sample population prevalences are each listed in the Tables.
Study selection and presentation
We identified studies of CMV shedding published from 1965 through 2009 by carrying out Medline searches using key words such as 'cytomegalovirus' or 'CMV' and 'shedding', 'culture', 'PCR', 'epidemiology', or 'prevalence'. Additional studies were identified through the reference lists in the articles we retrieved. Because there are numerous studies on CMV shedding, we limited the scope of the review by excluding studies that primarily focused on congenital CMV birth prevalence, breast feeding, shedding in amniotic fluid, HIV-infected individuals, organ transplant recipients, or assay validation. In general, we also excluded studies of fewer than 25 participants. However, we included all studies regardless of sample size that examined CMV viral load, duration of shedding, or frequency of sequelae in children with congenital CMV, because few studies addressed these topics.
Because of space constraints, tables (numbered A1-A5) whose data are displayed in figures are placed in the online appendix in order of appearance. Tables whose data are not displayed in figures are shown in the main text and numbered 1-3 in order of appearance. Study categories used in the various tables included congenitally infected children, healthy children enrolled in day care, healthy children not enrolled in day care, children with medical conditions, seroconverters, adolescents who were shedding CMV, adults with CMV risk factors, and adults without CMV risk factors. For congenitally infected children, diagnostic results were excluded because, by definition, the shedding prevalence at diagnosis is 100%.
RESULTS
From 56 studies, we identified 112 sample population prevalences measured in a single specimen type (e.g. urine, oral secretions) at a single point in time (Figure 1 , Tables A1 and  A2) . From these prevalences, we found that following their diagnosis at birth, congenitally infected children had the highest prevalences of shedding (median = 80%, N = 6). Among other children, shedding was more common among those in day care centers (median = 23%, N = 24) than among those not in day care centers (median = 12%, N = 11) or those with medical conditions (median = 9%, N = 7). Adults with CMV risk factors had prevalences of shedding similar to children in day care centers (median = 22%, N = 20), whereas adults without risk factors had the lowest prevalences of shedding (median = 7%, N = 44).
declined by the age of five (Figure 2 , panels B-E), although this age pattern was less pronounced in healthy children not in day care centers (Figure 2 , panel D). Results from the two studies reporting age and shedding among adolescents and adults (Table A3) [18, 19] suggest that prevalence may decrease with age [18] .
We identified 23 studies with 28 sets of sample population prevalences (Table A1) where CMV shedding was compared in more than one specimen type. Among children, CMV shedding was most commonly detected in urine specimens ( Figure 3 ) but was also prevalent in oral secretions (median prevalence difference = 11.5%, N = 12). In adults without risk factors for CMV shedding (N = 10), genital shedding was most common (although oral secretions were often not tested) (Figure 3 ). Adults with risk factors for CMV infection (N = 6) most often shed virus in urine, although in two studies [20, 21] shedding in other specimen types was more frequent (Figure 3) . Studies comparing shedding in multiple specimen types did not include certain specimens, such as semen, blood, and rectal secretions, frequently enough to provide insights into their relative shedding frequencies. In general, however, shedding prevalences in blood were lower than prevalences in other specimen types. Figure 4 displays the shedding data from 18 studies and 20 sets of sample population prevalences that measured shedding in multiple specimen types and/or multiple study visits. These data demonstrate, unsurprisingly, that if shedding is assessed in multiple specimen types at multiple times it is usually more likely to be found.
From five studies, we identified nine sets of sample population prevalences measured in a single specimen type at different times during pregnancy (Table A4) . Two of these sets came from the same women followed longitudinally throughout pregnancy [22] . The other sets came from cross-sectional samples of women at different times during pregnancy. The prevalence of CMV shedding in pregnant women increased generally with advancing gestation, reaching peak prevalences in the second and third trimesters ( Figure 5) . Two of the studies had non-pregnant control groups. In one of them [18] , shedding was less frequent in the first and second trimesters but equally frequent in the third trimester for the pregnant women compared with the non-pregnant controls. In the other study [22] , shedding was more frequent in every trimester for the pregnant women compared with the non-pregnant controls.
We identified four studies (Table 1) outside of the newborn period that assessed differences in CMV viral load by specimen type. No clear differences in viral load were present for the specimen types examined. Because of differences in how viral loads were measured, it was impossible to assess whether viral loads differed according to specimen type. Studies which compared different specimen types in the newborn period (excluded from this review) have found higher viral loads in urine than in blood [23, 24] .
In general, the risk for developing SNHL among congenitally infected newborns was strongly and consistently associated with higher viral load measured at birth ( Figure 6 , Table  A5 ). The six studies used different methods to determine viral load and set variable cut-offs for categorizing viral load. As such, direct comparisons of these studies may be difficult. Nevertheless, the risk for SNHL was not zero among newborns with low viral loads in most of the studies. Higher CMV viral load at birth also correlated with symptoms of congenital CMV at birth (Table 2 ). Although differences in mean viral load tended to be no more than 1-2 logs, they were consistent across all five studies.
Studies of the duration of CMV shedding were carried out in limited situations with highly variable follow-up frequency and duration (Table 3) . Consequently, it is not surprising that results varied widely. In general, congenitally infected infants and healthy children often shed for months or years. Among adult seroconverters, shedding typically continued for several months but had usually ceased within half a year. In several studies, shedding was intermittent among children and adults.
DISCUSSION
Studies of CMV shedding in various populations have provided valuable insights into the risk of acquiring CMV infection among women of reproductive age. This comprehensive analysis of CMV shedding among a variety of age groups, demographics and social settings, supports other findings that suggest that exposure to young children, especially those ages 1-2 years, poses a great risk for CMV infection [25] [26] [27] . Among young children shedding prevalences were lowest among infants less than 1-year-old. Prevalence of CMV shedding was uniformly high among 1-and 2-year-old children, whether they were enrolled in day care centers with large numbers of children or in home care. Thereafter, the prevalence of shedding declined markedly, although still continuing at relatively high levels among 3-4-year-olds. In the several studies that examined children older than five [11, 19, [28] [29] [30] [31] [32] , shedding prevalences were similar to those observed in adults (5-10%). Children in day care studied at the University of Alabama at Birmingham had higher prevalences of shedding overall than children in day care studied elsewhere ( Figure 1 , panels B and C), which may reflect differences in the underlying study populations such as race, socioeconomic status, or mother's serostatus. One notable difference in shedding patterns occurred among children with serious medical conditions, where in several studies the prevalence of shedding stayed at low levels throughout childhood ( Figure 2 , panel E), perhaps reflecting fewer opportunities for exposure.
Children ages 1-2 years may be a key transmission risk not only because of their high shedding prevalences, but because they are more mobile than younger children and are more likely than older children to spread urine or oral secretions to others because they are not yet toilet trained (e.g. still in diapers) and are more likely to drool (e.g. because of teething). Thus, caregivers who are pregnant or planning a pregnancy should make extra efforts to follow hygienic precautions with 1-2-year-olds [33, 34] . Furthermore, providers in day care centers may have lower risk when caring for infants or for older children.
Among children, CMV shedding occurs most frequently in urine but is also commonly found in oral secretions. These studies support the existing consensus that pregnant women should avoid getting urine or saliva in their eyes, nose, or mouth [35] [36] [37] [38] . Based on these data, sensible prevention activities for pregnant women would include hand washing after diaper changes or wiping a child's nose or face and avoiding saliva when kissing young children and not sharing food, drink, utensils, or towels.
Adults typically shed CMV less frequently than children, but their prevalence of shedding is rarely zero. Furthermore, contrary to what is sometimes stated in the literature, seroconverting adults shed for many months rather than weeks. Among adults, genital secretions are a common fluid for CMV shedding, consistent with other studies that identified sexual risk factors for CMV seropositivity or seroconversion [25, [39] [40] [41] [42] [43] . However, adults also shed CMV in oral secretions, suggesting that CMV transmission among adults can occur through kissing or oral sex. Unfortunately, it may be difficult if not impossible to assess the relative risk of these frequently co-occurring intimate behaviors. This presents a challenge for advising women on precautions to take with intimate partners during pregnancy. At a minimum, it would be prudent to limit new sex partners during pregnancy and to use a condom with new partners, even though these practices would not eliminate the risk for oral transmission. In many cases, the risk from regular partners may be less because they typically share the same CMV serostatus-for example, in one very large study in Belgium only 20% of seronegative women had a seropositive partner [26] .
Among the different risk groups, children born with congenital CMV infection displayed the highest prevalences of subsequent CMV shedding (Figures 1 and 2 ). However, a substantial proportion of healthy children also shed CMV, reinforcing the notion that children with congenital CMV do not pose a special risk in day care or classroom settings and should not be excluded or treated differently.
Although the risk of CMV exposure for women of reproductive age may be elevated when their child attends day care, the risk is by no means eliminated for women who care for their children at home. About 20% of children in day care centers are shedding CMV, but about 10% of children not in day care centers are also shedding ( Figure 2 ). As such, pregnant women should follow hygienic precautions whether or not their young children attend day care centers.
Studies that only measure CMV shedding in one specimen type at one point in time invariably underestimate the number of individuals who are shedders. This is because CMV shedding is frequently intermittent [44] and because CMV is shed in some specimen types more frequently than others. Thus, the shedding prevalences in the different risk groups (Figure 1 ) should be treated as minimum estimates of the prevalence of individuals shedding in bodily fluids. Furthermore, care must be taken when comparing shedding prevalences across studies, because some may present results from a single specimen and time point whereas others combine results from multiple specimens or time points.
Viral shedding was more common among pregnant women as gestation progressed for all five studies that have examined this phenomenon (Table A4) . It is not clear why this phenomenon occurs, but because there is no apparent reason why exposure risk should increase with advancing gestation, it may be that this trend is related to a possible altered state of immunity during pregnancy [45, 46] , which could increase the likelihood of CMV primary infection, reactivation, or reinfection, as well as the duration of viral shedding [47] [48] [49] .
Approximately from 10% to 15% of congenitally infected children who have asymptomatic infections at birth will develop disabilities within 2 years, most often SNHL [4, 50] . It does not appear that CMV shedding or viral load measured after the newborn period is a strong predictor of SNHL [44, 51] . In contrast, the observation that the highest viral loads at birth are consistently associated with the greatest risk for developing hearing impairments should be useful for clinical prognoses. However, the positive predictive value of high viral load for SNHL is probably only 30%-80% whereas the negative predictive value of low viral load probably ranges from 50% to 100% depending on the chosen assay cut-off ( Figure 6 ). Nevertheless, all congenitally infected children would probably benefit from regular followup audiological testing, but such follow up would be especially important for children with high viral loads at birth.
The findings from CMV shedding studies tended to be consistent with serologic studies that addressed risk factors for CMV transmission [25, 52] . Nonetheless, the studies we reviewed had significant differences in study design, population demographics, number of participants studied, and other factors that limited the conclusions we could draw. The majority of studies used viral culture to isolate infectious virus. However, for those studies that used PCR, there was no way to know how well the presence of viral DNA correlated with the presence of infectious virus in any given bodily fluid. Additional studies are needed in a household setting where much child-to-mother transmission is likely to occur [15, 53] . Finally, studies comparing a broad selection of clinical specimens (urine, saliva, blood in children; urine, saliva, blood, genital secretions, semen in adults) at multiple time points are needed to better understand and prevent CMV transmission to pregnant women.
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